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Drug use in prisons and its related consequences are issues of considerable political concern. It 
is possible to draw a general picture of the situation in Europe based on data available at the 
European level, but there are significant limitations in the data and wide gaps in its availability, 
particularly when assessing the wider European picture and comparing individual countries.  
The European Monitoring Centre for Drugs and Drug Addiction (EMCDDA) is required to collect 
information at the European level on drugs, drug addiction and their consequences, including the 
issue of drugs in prisons. As a first step in addressing gaps in the data on drug use in prisons, 
the EMCDDA gathered more than 40 questionnaires on drug use among prisoners that are 
currently being used in European prisons. This paper assesses the quality of the information 
collected by the surveys, exploring commonalities and differences between countries. The 
assessment will be used to create a standardised European questionnaire on prison drug use 
and related consequences that can be used in all European countries. 
 
1.1 Prisons and drug use 
According to the latest available data on the prison population, on 1 September 2010 there were 
an estimated 635 000 prison inmates in EU Member States. Most prisoners are from poor 
communities and vulnerable social groups, with the proportion who are immigrants or from 
minority ethnic backgrounds on the increase. 
Drug users form a large part of the overall prison population. Studies show that a majority of 
prisoners have used illicit drugs at some point in their life, and many have chronic and 
problematic drug use patterns. Because of the illegality of the drugs market and the high cost of 
drug use, which is often funded by criminal activity, the more problematic forms of drug use are 
accompanied by an increased risk of imprisonment. Although some individuals do stop or reduce 
their use of drugs when they are sent to prison, others initiate drug use or engage in more 
damaging behaviours when they are incarcerated. In addition to high levels of drug problems, 
prisoners also experience poorer health than the general population, with higher prevalence of 
blood-borne infections such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV), 
as well as high rates of mental illness. Reported rates of self-harm and suicide among prisoners 
are particularly high compared with the general population of the same age. Overcrowding and 
poor hygiene may further aggravate the stress, social and health problems experienced by 
prisoners. For opioid users, the risk of dying from drug overdose greatly increases in the period 
after release from prison, due to high rates of relapse and lower opioid tolerance (Aebi and 
Delgrande, 2011; EMCDDA, 2012; WHO, 2007).  
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In 2012 the EMCDDA published a special report, Selected issue 2012: Prisons and drugs in 
Europe — the problems and responses (EMCDDA, 2012), based primarily on data provided by 
the Reitox network of national focal points, (1) through either yearly routine reporting or a special 
data collection. It provides an overview of the most recent available data on drug use and 
responses in European prisons. The data include both qualitative information on drug use in 
prisons and quantitative data on prevalence and patterns of drug use among prisoners. However, 
there are methodological limitations — the data are scarce and there is no common 
methodology for monitoring drug use in prison. The EMCDDA is therefore working towards 
increased harmonisation. 
 
1.2 The institutional mandate and the work carried out at the EMCDDA 
A requirement to monitor the issue of drug use, related problems and responses in prisons is 
specified in the priorities of European institutions. The EMCDDA in particular is required, as a 
primary objective, to collect factual, objective, reliable and comparable information at the 
European level on drugs, drug addiction and their consequences; this includes the issue of 
drugs in prisons. The data collection work carried out at the EMCDDA on drugs and prisons has 
focused on drug use prevalence and patterns of drug use before and during prison, health 
problems related to drug use among the prison population and interventions targeting drug users 
in prison. Specific instruments for data collection and reporting from the national focal points to 
the EMCDDA have been developed, including standard tables and national reports. 
Since the mid-1990s the EMCDDA has worked with external consultants on this topic on several 
projects, mainly focusing on methodological aspects of data collection in prisons and 
interventions targeting drug users in prison. Several outputs have been produced, including the 
2012 Selected issue. From the outset, the EMCDDA has also worked in close collaboration with 
international partners on the issue of drugs and prisons, and in particular with the World Health 
Organization (WHO) Office for Europe’s Health in Prisons Programme (HIPP), the European 
Centre for Disease Prevention and Control (ECDC) and the United Nations Office on Drugs and 
Crime (UNODC). The EMCDDA also contributes regularly to EU-funded projects in the field of 
drugs and prison.  
The EMCDDA’s task of collecting information on drugs and prisons is reinforced by the mandate 
of the European Commission. The EU action plan 2009–12 (objective 9) states that Member 
States should provide access to health care for drug users in prison, to prevent and reduce 
health-related harms associated with drug use, and identifies two specific actions to support this 
                                                    
(1) Reitox is the European information network on drugs and drug addiction created at the same time as the EMCDDA. 
The abbreviation ‘Reitox’ stands for the French ‘Réseau Européen d Information sur les Drogues et les Toxicomanies’. 
Members of the Reitox network are designated national institutions or agencies responsible for data collection and 
reporting on drugs and drug addiction. These institutions are called ‘national focal points’ or ‘national drug observatories’. 
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objective: Actions 21 and 22. Action 22 indicates that Member States must endorse and 
implement in prison settings indicators to monitor drug use, drug-related health problems and 
drug services delivery on the basis of a methodological framework developed by the 
Commission — with the support of the EMCDDA — that is compatible with existing 
methodologies, and taking into account the work done by UNODC (in the area of HIV/AIDS and 
treatment) and by WHO (in relation to health in prisons). 
The EMCDDA, together with national experts and international organisations, has therefore 
written a document that defines the methodological framework for collecting data on drugs and 
prisons in European countries. This was presented during a meeting of the Horizontal Drug 
Group of the Council of the European Union (Council of the European Union, 5420/1/13-
CORDROGUE 7 –SAN 19) in February 2013. That document sets the basis for the development 
of common instruments for data collection on drugs and prisons in the EU Member States. 
 
1.3 The methodological framework 
The need to define a common methodological framework has been driven by the necessity to 
have a clear and harmonised picture of the situation so that the availability and effectiveness of 
interventions targeting drug users in European prisons can be analysed, and trends can be 
followed over time.  
A common and harmonised approach at European level is needed: 
• to identify the extent and nature of the drug problem affecting the prison population in all 
European countries, with no exceptions; 
• to quantify and describe the characteristics of European prisoners, and their health and 
social needs in relation to drug use; 
• because currently available information on drugs and prison in Europe is fragmented, 
incomplete and mostly not comparable across countries.  
In the methodological framework the following five areas of information are identified: 
background information on prison populations; drug use among the prison population; health 
problems among drug users in prison; service provision for drug users in prison; and drug-
related adverse effects after prison release. 
Some information already exists and can be obtained through existing tools from the EMCDDA 
or other international organisations (Council of Europe, WHO, UNODC). Other information needs 
to be collected through new tools harmonised at the European level, based on national tools 
adapted and harmonised in a European data collection instrument. In particular, two tools have 
been identified: a common EU questionnaire on drugs use and its related consequences among 
prisoners; and an EU survey on facilities targeting drug users in prison. 
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The current report focuses on the first tool, and concludes by defining a common European 
questionnaire based on the assessment of existing national tools used in European countries. 
 
1.4 The need for a harmonised European questionnaire 
At the European level the information on drugs and prisons is lacking. In fact, information at the 
national level is rare, and does not cover all relevant aspects of the issue. Also, the information 
collected at the national level does not cover all prisons, is not collected regularly, so trends 
cannot be described, and its comparability at the European level is low.  
The information is often based on differing methodologies (e.g. routine data collection, ad hoc 
studies, surveys, etc.); study samples may vary considerably in size and are often not 
representative of the whole prison system and prison population; periods of data collection may 
differ by country and prison. Much of the available data from EU Member States come from ad 
hoc studies among prisoners carried out at the local level. Furthermore, there is a lack of 
repeated surveys. All these methodological limitations in data comparability make extrapolation 
of a national and European overview figure for the prison system and population very difficult, 
and limit trend analysis in most EU Member States. 
Some general principles must be established in order to develop a harmonised European tool:  
• Existing data sources at national, European and international levels must be reviewed.  
• When data collection tools are defined, both the data collection at the national level and 
reporting to the EMCDDA should be considered.  
• The data collection instrument should focus on a minimum dataset, including only the 
most important items to describe drug use, health problems and service needs among 
prisoners in Europe.  
• The questionnaire should be accompanied by methodological guidelines. 
Some priority areas have been identified as a minimum common basis to be covered by the data 
collection:  
• information on drug use prevalence (before/inside prison, initiation/continuation);  
• patterns of drug use (frequency, route of administration, risk behaviour);  
• infectious diseases;  
• demographic data;  
• service use;  
• needs inside prison. 
On the basis of these areas and of the assessment of national tools, a proposal for a common 
European questionnaire is presented as the conclusion of the current report.  
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2. Mapping and assessment of national questionnaires on drug 
use and related questionnaires in prison 
2.1 Objectives and method of the project  
Over the last decade, several studies on drug use among the prison population in Europe have 
been conducted, and in many countries routine monitoring systems are in place. The purpose of 
this study is to develop a European Questionnaire on Drug use among Prisoners (EQDP), based 
on the assessment of existing national data collection tools.  
In summer 2012 a request was sent to national focal points (NFPs) for them to send in existing 
surveys/questionnaires used at the national level for collecting data on drug use among 
prisoners. All countries provided the questionnaire and related documents in their national 
language. Most non-English speaking countries also provided a translation in English. A few 
countries only provided a non-English questionnaire, and in these cases the key areas were 
translated into English by this project. The exercise was voluntary and the countries were keen 
to participate, sending in more than 40 questionnaires. When a particular survey was mentioned 
in a country’s national report, it was specifically requested. Guidelines and codebooks were also 
collected.  
Four questionnaires used by non-EU countries or international organisations were collected as 
external reference: South Asia Knowledge, Attitude and Practice in Prison Populations 
(SAKAPiPP); the Inter-American Uniform Drug Use Data System (SIDUC) used to survey drug 
use among the prison population; Toolkit for HIV Situation and Needs Assessment in Prisons; 
and the Australian National Prison Entrants’ Bloodborne Virus and Risk Behaviour Survey.  
All questionnaires were entered into an Excel database and, based on the most complete 
survey, an assessment template was created. The template was used as a reference point for 
assessing commonalities and differences between the national questionnaires. The analysis only 
concerned the areas of drug use, related consequences and service needs among prisoners in 
European countries. The wording of each question was assessed according to criteria identified 
in the methodological framework and during a literature analysis.  
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The following analytical categories were identified:  
a. Socio-demographic information 
(gender, age, citizenship, ethnicity, level of education, job situation before prison, marital status, 
accommodation, cohabitation/living with whom, parental status)  
b. Legal status 
(prisoner’s status, type of offence, length of current prison sentence, time served/remaining, how 
many times in prison, contact with criminal justice system, age at first arrest, probations, past 
imprisonments)  
c. Substance use 
(drug use before prison/lifetime, drug use in prison, type of drug, frequency of drug use, amount 
of drug use, route of administration, injecting behaviour, overdose, drug-related crimes, 
likelihood of consumption after release, tobacco)  
d. Risk behaviour 
(sharing injecting equipment, tattooing/piercing, sexual intercourse without condom, sharing 
shaving material, disinfecting, other risk behaviours)  
e. Sexual behaviour 
(consensual/not consensual, other sexual behaviours)  
f. Prison 
(type of prison, custodial interventions, prison conditions, prison staff, prisoner occupation, 
others)  
g. Health status 
(heath care, health status: physical health, mental health)   
h. Infectious disease tests 
(HIV test, HIV result, hepatitis B test, hepatitis B result, hepatitis C test, hepatitis C result, 
hepatitis vaccine, other infectious disease tests) 
i. Drug treatment 
(need for treatment, previous treatments, treatment in prison, modality of treatment, treated by 
whom/where, length of treatment, number of times treated, type of drug use treated, other drug 
treatment, source of referral) 
l. Support 




2.2 The country questionnaires  
A total of 45 questionnaires or registration forms were sent to the EMCDDA, plus other related 
documents, such as guidelines or codebooks. All NFPs except one (Turkey) replied to the 
request. Overall, 23 NFPs submitted questionnaires and/or other documents (see Table 1). Six 
countries (Germany, Malta, Austria, Poland, Slovenia and Norway) did not submit any 
documents, for a variety of reasons — either because a single national questionnaire did not 
exist, or because the questionnaires were unavailable, or for other reasons. The questionnaires 
that were received mainly targeted prisoners, with prison staff also targeted to a minor extent. 
The questionnaires are available on the EMCDDA website at 
http://www.emcdda.europa.eu/topics/prison (see Table 1). 
 
Table 1. Questionnaires and related documents provided by NFPs (Reitox NFPs, 2013) 
Country Status Type 
Belgium Translated into English Questionnaire (prisoners) 
Bulgaria Translated into English Questionnaire (prisoners)  
Czech Republic Translated into English Questionnaire (prisoners)  
Denmark Translated into English Questionnaire (prisoners)  
Registration form for treatment clinics (not prison, not 
translated) 
Registration form 
Refusing schedule form 
Germany Not available  
Estonia Translated into English Questionnaire (prisoners)  
Ireland Provided in English Questionnaire (prison staff) 
Greece Translated into English Questionnaire (prisoners) 
Questionnaire (therapy) 
Spain Translated into English 
(short version) 
Full version in Spanish 
Questionnaire (prisoners) Guidelines for interviewer 
France Translated into English 
and French version  
Questionnaire (prisoners, PREVACAR) 
Questionnaire (prison services) 
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Questionnaire (prisons, infectious diseases PRI2DE) 
Italy Translated into English Data reporting form for detention institutions  
Questionnaire on drugs (prisoners, adult)  
Questionnaire on alcohol (prisoners, adult) 
Questionnaire on drugs (prisoners, juvenile) 
Questionnaire on alcohol (prisoners, juvenile) 
Several questionnaires depending on type of institution for 
minors 
Cyprus Translated into English Data reporting form for detention institutions 
Latvia Translated into English Questionnaire (prisoners) 
Lithuania Translated into English Questionnaire (therapy) 
Luxembourg Translated into English Questionnaire (therapy) 
Hungary Translated into English Questionnaire (prisoners) 
Malta None exist  
Netherlands Translated into English Questionnaire (prisoners) 
Austria None exist  
Poland Not available  
Portugal Translated into English Questionnaire 2001 (prisoners)  
Questionnaire 2001 (prison staff and Director)  
Questionnaire 2007 (prisoners)  
Questionnaire 2007 (prison staff and Director)       
Romania Translated into English Questionnaire (prisoners) 
Slovenia None exist  
Slovakia Translated into English Drug testing data collection form 
Finland Translated into English Questionnaire (prisoners) 
Sweden Translated into English Questionnaire (drugs) 
Questionnaire (alcohol) 




England and Wales  questionnaire  (prisoners) – pre-
release 
England data reporting form 
Scotland questionnaire (prisoners)  
England questionnaire  about mandatory drug test in 
prison (prison staff and prisoners) 
England  and Wales questionnaire (prisoners) – ethnicity, 
nationality, religion, age and disability 
Croatia Translated into English Data reporting form for detention institutions 
Norway Not available  
Questionnaires and related documents from other countries and international organisations 
UNODC – South 
Asia 
Provided in English Questionnaire (prisoners) 
 
CICAD Provided in English Questionnaire (prisoners) 
Australia Provided in English Questionnaire (prisoners) 
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3. The assessment results 
The questionnaires provided information on several areas of the prisoners’ life and referred to 
two time windows: before entering prison, and inside prison. The areas of information 
overlapped with those identified in the methodological framework: socio-demographic 
information, health status, drug use and related health problems, risk behaviours (drug-related or 
not), and infectious diseases. Some questionnaires also covered other issues, such as work 
status and living status, relationships with other inmates, etc. 
The following is an analysis of the different aspects and information areas that the 
questionnaires provided, addressing the commonality and difference between questionnaires. 
 
3.1 Methodology of the questionnaires (Table 2) 
Methodological aspects include the aim of the survey, the year of data collection, the institution 
responsible for data collection and management, the target population, sampling, the 
length/duration of the questionnaires, method of data collection, the level of participation, the 
language used and ethical issues.  
Aim  
The main aim of most studies was related to public health, and encompassed prisoners’ health, 
drug use and related health problems, risk behaviours and infectious diseases.  
Year  
The questionnaires were quite recent, with 13 conducted after 2009.  
Responsible institution 
The institution responsible for conducting the study or the data collection was mainly the prison 
and probation service or the ministry of health. In a few cases the surveys were led by 
universities. The United Kingdom’s survey was carried out by the Home Office.  
Target population 
Nearly all of the questionnaires targeted the prison population, either on remand or convicted. 
The prisons themselves were the target of the data collection in two cases (Italy and Cyprus). In 
France the questionnaire targeted both prisoners and prisons. Some targeted prison staff in 
addition to prisoners (Ireland, Portugal and the United Kingdom), or the prison director 
(Portugal).   
Sampling  
Around half of the questionnaires were applied using random samples of prisoners; in the case 




Information on the average duration of the interview was only available for three countries; in 
those countries the time for conducting the interview was around 60 minutes. For the remaining 
countries, most questionnaires were quite concise, except for the United Kingdom, where the 
questionnaire was quite long and conducted in two waves (at reception and on release). The 
duration of the interview usually varied according to the type of drug consumption of the 
respondents and their previous offending. Drug users with a longer history of drug use and 
offending could spend more time in the interview. Another factor that could prolong the duration 
of the interview was the prisoners’ illiteracy, which obliged the interviewers to read out show-
cards. The studies covering several areas of information were longer. 
Method of data collection 
Surveys were carried out using different methods. Some were self-administered; after filling in 
the questionnaires the prisoner put the survey in an envelope and sent it to the researchers. 
Others were face-to-face interviews carried out by trained interviewers. The United Kingdom 
used a face-to-face computer-assisted personal interview in two waves, at reception and pre-
release. This method has the advantage of incorporating consistency checks.  
Participation  
Participation in the studies was voluntary in most cases; however, sometimes questionnaires 
were mandatory when used as a routine monitoring system (Bulgaria and Sweden) or when the 
target of data collection was the prison institution (Italy and Cyprus). The data coverage of 
prisons varied between countries, with France reporting the highest coverage and Cyprus the 
lowest.  
Language 
All countries provided the questionnaire and related documents in their national language. Most 
non-English speaking countries also provided a translation in English. A few countries only 
provided a non-English questionnaire, and in these cases the key areas were translated into 
English by this project.  
Ethical issues 
The rationale of the study was explained and information on this aspect matched in all 
questionnaires. Anonymity was guaranteed in most cases.   
 
Table 2 lists the questionnaires according to the methodological information.  
Year Rational of the study Anonymity
Who conducts the study/
Data Collection System Aim Target population Time for application Participation
Nº of imprisonment 
Institutions Sample size Language
Belgium 2010 Help prisoners to cope with drug problems Yes
Prison Health Service/ University 
Ghent Health in general All prison users / not users 15-30 minutes Voluntary 32 10% of prisoners (n= 1251) Translated to English
Bulgaria 2011 : : Nationwide routine self-reported Data Collection System Health in general
All convicted, defendant adults
 and detainees n.a. Compulsory 17
All prisoners 
(n= 9885)
Original Bulgarian & translated 
to English
Czech Republic 2010 Improve conditions of drug counselling & treatment services Yes
National Monitoring Centre for Drugs 
and Drug Addiction
Improve conditions of drug 
counselling & treatment services All prisoners n.a. Voluntary 35
Randomly selected
 (n=1668) 
Original Czech & Translated to 
English
Denmark 2001 Alcohol and Drug Survey Yes Prison and Probation Service Alcohol and Drug Survey All remand and convicted prisoners n.a. Voluntary 82 Prisoners
 (n=1305)
Original Danish & translated to 
English
Germany : : : : : : : : : : :
Estonia 2011 Planning for HIV and infection-related 
services Yes Health Development Institute
Planning for HIV and infection-related 
services All prisoners n.a. Voluntary 5 All prisoners 
Original Estonian & translated 
to English
Ireland 2012 Prevalence of drug use, injection & blood borne virus Yes
National Advisory Committee on 
Drugs, Irish Prison Service 
Estimate prevalence of drug use & 
blood borne virus among prisoners All prisoners n.a. Voluntary 14
Random sample of sentenced 
and remand prisoners  (n= 800) Provided in English
Greece
Spain 2006
Prevalence and patterns of drug use and 
related risk behaviours among prison 
inmates
Yes Ministry of Health Health and Drug use of prisoners All prisoners n.a. Voluntary 66 Random sample of prisoners (n= 4934)
Original French & translated to 
English
France 2010 Study HIV,  HCV and/or substitution treatment opiates in prison Yes
Ministry of Health, Institute of Public 
Health (PREVACAR)
Estimate HIV,  HCV and/or 
substitution treatment prevalence All prisoners / prisons n.a. Voluntary 145
All prisoners (n=56011) /
prisons (n=145)
Original French & translated to 
English
Italy 2010 Prison data monitoring :
Department for Antidrug Policies of the 
Presidency of the Council and the 
Ministry of Health
Monitoring data on prisoners with 
drug-related health problems Prisons n.a. Compulsory All prisons
Original Italian & translated to 
English
Cyprus 2011 Prison data monitoring : Prison Department,(Ministry Justice & Public Order) Statistics Prisons n.a. Compulsory 1 All prisons Translated to English
Latvia 2010 Situation in prisons regarding drug and drug use Yes
Centre for Health Economics, 
Sociological Research Institute.
Planning for improvement of situation 
in prisons All prisoners n.a. Voluntary 11 Convicted inmates (n=1965)
Original Latvian & translated to 
English
Lithuania : : : : : : : : : : :
Luxembourg : : : : : : : : : : :
Hungary 2008 Examine risk behaviours of infectious diseases transmission Yes National Criminology Institute
Risk behaviours of infectious 
diseases transmission All prisoners n.a. Voluntary 22
Proportional sample of convicted 
prisoners (n=503)
Original Hungarian & 
translated to English
Malta : : : : : : : : : : :
Netherlands 2012  Situation in prisons regarding tattooing 
and drug injection. Yes University of Amsterdam Health in general
Prisoners in prisons and detention 
houses n.a. Voluntary 33
:
Original Dutch & translated to 
English
Austria : : : : : : : : : : :
Poland : : : : : : : : : : :
Portugal 2007 Situation in prisons regarding drug use 
and drug related problems Yes
Serviço de Intervenção nos 
Comportamentos Aditivos e nas 
Dependências (SICAD)
Monitoring data on prisoners with 
drug-related health problems All remand and convicted prisoners n.a. Voluntary 44
Random sample of convicted and 
remand prisoners (n=1986)
Original Portuguese & 
translated to English
Romania 2011 Situation in prisons regarding drug use 
and drug related problems Yes
Romanian Monitoring Centre for Drugs 
and Drug Addiction
Monitoring data on prisoners with 
drug-related health problems All remand and convicted prisoners 20-30 minutes Voluntary 27
Probabilistic, stratified and 
multistage sampling (n=2064)
Original Rumanian & 
translated to English
Slovenia : : : : : : : : : : :
Slovakia : : : : : : : : : : :
Finland 2006 Health state, morbidity, associatedlevel of disability & treatment needs Yes
University of Tampere/
Criminal Sanctions Agency Health and treatment needs All prisoners n.a. Voluntary 37
Random sample
(n=711)
Original Finish & translated to 
English drug use section
Sweden : Assessment, follow-up, for planning and development of care and treatment Yes
Institute for the development of 
methods in social work (IMS)
Assessment of prisoners with alcohol 
and drug-related problems All prisoners n.a. Compulsory : Prison and probation system
Original Swedish ASI & 
translated to English
United Kingdom
(England & Wales) 2005-2010
Improve policy making, decision taking 
and practice Yes
Ipsos MORI
Home Office and Ministry of Justice
Explore how interventions might work 
in combination to address the range 
of prisoners’ needs
Recently sentenced prisoners 59 minutes Voluntary 47 Sample of recently sentenced prisoners  (n=3849)
Provided in English Surveying 
Prisoner Crime Reduction 
(SPCR)
Croatia 2011 Prison data monitoring : Nationwide routine self-reported Data Collection System Health, diagnostics and programming
All admissions at entry; 
convicted & 6 months of servitude n.a. Compulsory 22
All prisoners at entry
(n= 2133) Translated to English
Turkey : : : : : : : : : : :
Norway : : : : : : : : : : :
Table 2. Characteristics of questionnaires submitted by EU Member States, Turkey and Norway
3.2 The content analysis: areas of information (Table 3) 
The information covered by the questionnaires was assessed, focusing only on drug-related 
information, even if several questionnaires covered other non drug-related areas. 
Furthermore, since the common questionnaire will only gather epidemiological information, 
the assessment only focused on a small number of questions identified in the priority areas 
defined in the methodological framework (see paragraph 2.1).  
A short description for each of the areas is provided below.  
Number of questions 
The number of questions included in the surveys varied between countries, from 10 to more 
than 100.   
Subject areas 
The subject areas covered ranged from a few to many, including health, crime-related 
questions, drug use, alcohol and tobacco use, interventions, behaviours and infectious 
diseases, among others. Most questionnaires also covered wider drug-related issues.  
Drug use before or inside prison 
Questions related to drug use before entering prison or inside prison were found in all 
questionnaires. However, not all of them included questions related to all legal or illegal 
drugs. Only six countries were interested in prisoners’ tobacco use (Estonia, Spain, Latvia, 
Finland, Sweden and the United Kingdom). More than ten countries (particularly the Nordic 
countries) asked about alcohol consumption. A key issue found in most surveys was related 
to the consumption of non-prescribed medicines (benzodiazepines, hypnotics, 
antiparkinsonian, etc.), including methadone and buprenorphine. The use of heroin, cannabis, 
cocaine and amphetamine, the four main illegal drugs leading to drug-related problems in 
Europe, was investigated in the majority of questionnaires. Questions regarding other drugs, 
such as inhalants, ecstasy, LSD, magic mushrooms, were found in many of the surveys.  
Patterns of drug use 
The questionnaires asked about lifetime prevalence, last year (last 12 months) and last month 
(last 30 days) prevalence for the different drugs. Six countries also included questions about 
the age of first use (Denmark, Estonia, Spain, Romania, Sweden and the United Kingdom). 
Only a third of the countries asked about the frequency of drug use and eight countries asked 
about the main route of drug administration. Most countries asked about drug injection but 





About a third of the countries included questions regarding risk behaviours, either related to 
drug use, or to sexual behaviours and other risks behaviours (e.g. tattooing, piercing, sharing 
of razors and/or other personal hygiene equipment, such as a toothbrush).  
Infectious diseases 
Questions related to HIV and HCV prevalence, tests and results were found in more than a 
third of the questionnaires. About one-third of the questionnaires included questions on HBV 
tests, results and vaccination. Few countries asked prisoners about TB infection and 
treatment.  
 
Number of questionnaires/data collection forms Belgium Bulgaria
Czech 
Republic Denmark Germany Estonia Ireland Greece Spain France Italy Cyprus Latvia Lithuania Luxembourg Hungary Malta Netherlands Austria Poland Portugal Romania Slovenia Slovakia Finland Sweden
United 





health √ √ √ √ √ √ 0
drug use √ √ √ √ √ √ √ √ √ 0
intervention √ √ √ 0
behaviours √ 0
infectious diseases √ √ √ √ 0
Template
Target population
prisoners √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 17
staff √ √ √ 3
prisons √ √ √ √ √ √ 6
prison directors √ 1
others 0
Methodology
sample √ √ √ √ √ √ √ √ √ 9
all prisoners √ √ √ 3
prison entry √ 1
clinical assessment 0
administrative control √ 1
periodical survey √ √ √ 3
Focus on drugs and prison
drug use prevalence √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 18
health status √ √ √ √ √ √ 6
socio-demographic info √ √ √ √ √ √ √ √ √ √ √ √ 12
treatment √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 17
others √ √ √ √ 4
Drug use prevalence/patterns
type of drug - breakdown √ √ √ √ √ √ √ √ √ √ √ √ √ √ 14
time spam: Lifetime Prevalence √ √ √ √ √ √ √ √ √ √ √ 11
time spam: Last Year Prevalence √ √ √ √ √ √ √ √ 8
time spam: Last Month Prevalence √ √ √ √ √ √ √ √ 8
age of first use of drug √ √ √ √ √ √ 6
injection of drugs √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 16
frequency of drug use √ √ √ √ √ √ √ √ √ √ 10
route of administration of drugs √ √ √ √ √ √ √ √ 8
age of first injecting use of drug √ √ √ √ √ √ 6
Drugs
tobacco √ √ √ √ √ √ 6
alcohol √ √ √ √ √ √ √ √ √ √ √ √ 12
heroin √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 17
cannabis √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 18
cocaine √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 18
amphetamines √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 17
methamphetamines √ √ √ 3
inhalants √ √ √ √ √ √ √ √ √ √ √ √ 12
unprescribed medicines √ √ √ √ √ √ √ √ √ √ √ √ 12
unprescribed methadone/subutex √ √ √ √ √ √ √ √ √ √ √ 11
ecstasy √ √ √ √ √ √ √ √ √ √ √ √ √ √ √ 15
LSD √ √ √ √ √ √ √ √ √ √ √ √ 12
magic mushrooms √ √ √ √ √ √ √ 7
others √ √ √ √ √ √ √ √ √ √ √ √ √ √ 14
Risk behaviours
Related to drugs √ √ √ √ √ √ √ √ √ 9
Related to sexual behaviours √ √ √ √ √ 5
Related to other √ √ √ √ √ 5
Infectious diseases
HIV √ √ √ √ √ √ √ √ √ √ √ √ 12
HCV √ √ √ √ √ √ √ √ √ √ √ √ 12
HBV √ √ √ √ √ √ √ √ √ 9
TB √ √ √ √ √ 5
Table 3. Type of questionnaires, target population and drug use related questions for EU Member States, Turkey and Norway  
3.3 The main questions  
Following the analysis of the broad content areas covered by the questionnaires, some key 
questions were analysed. The clarity of the wording used, the presence of polar questions, 
the existing biases and the number and type of drugs investigated were assessed.   
3.3.1 Lifetime drug use (Table 4)  
Twelve countries’ surveys included questions related to prisoners’ drug use before entering 
prison. In all cases the wording was clear, included all the necessary information and was 
adapted to prisoners’ reading skills, taking into account the particular purpose of the question. 
However, none of the countries used the same wording for these questions. The sentences 
varied from very short phrases such as ‘Tried [drug] ever’ (Denmark) to several questions, 
such as ‘Have you ever in your life, inside or outside prison, used other drugs than alcohol (all 
illegal drugs, also marihuana and hashish)?’ (Belgium), and ‘Which drugs have you ever used 
in your life?’ (Belgium).  
Clarity of wording 
Due to the impact of language barriers and the translation to English conducted either by the 
country itself or at the EMCDDA, all questions varied between countries in the number and 
type of words used. However, in seven countries the questions started or ended with the 
same wording: ‘Have you ever…’. When questions referred to ‘lifetime prevalence’ of drug 
use, different expressions were used, such as ‘have you ever’, ‘ever’, ‘in your life’ or ‘during 
the life’.  
Polar questions  
Most surveys included polar questions (where the expected answer is either ‘yes’ or ‘no’). The 
order of the answers (‘yes’ or ‘no’) differed, with two countries presenting ‘no’ as the first 
option, and six putting ‘yes’ first. In a few cases the answers defined the categories for the 
frequency of drug consumption. For example, in Bulgaria possible answers to the question 
‘Have you ever used [drug] in lifetime?’ were: ‘Never’, ‘At least once’, ‘At least 10 times in the 
last month or at least 30 times in the last year’.  
Biases 
In all countries the response categories were clear and mutually exclusive; no biases were 
identified in the questions. However, in a few cases the questions covered several issues 
(use and frequency) in only one question.   
Number and types of drugs 
The list of drugs in some cases was quite extensive, varying from four to 15 drugs, from a few 
substances in France (heroin, cocaine, crack, free-base, other) to a full list of different 
substances in Belgium and Spain. All questionnaires included heroin, cannabis, cocaine and 
amphetamines. Questions related to ecstasy use were included in half of the questionnaires. 
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Before entering prison Questions Answers Drugs
Belgium
-  Have you ever in your life, inside or outside prison, used other 
drugs than alcohol (all illegal drugs, also marihuana and hashish)?
-  Which drugs have you ever used in your life?
- no  - yes
Heroin; cocaine, crack; speed, amphetamines; ecstasy; GHB (liquid XTC); LSD or 
mushroom; methadone or Subutex: black market; hashish, marihuana; sleeping pills 
or sedatives of the black market; Valium, Lexotan, (“Roche”); ketamine; self-
prepared mixtures; other (fill in).
Bulgaria Have you ever used DRUGS in lifetime?
-   Never   
-   at least once   
-   at least 10 times in the last month or at least 30 
times in the last year 
Cannabis (marijuana, hashish, ganja); cocaine (including crack); heroin; ecstasy; 
others (morphine, codeine, lido, methadone substitol, methamphetamine, LSD, 
hallucinogenic mushrooms, adhesives, bronze, etc.)..
Czech Republic Please circle whether you have before entering prisontake one of the listed substances.
-   During last months   
-   during last year  
-   during the life  
-   never
Alcohol; marijuana / hashish; ecstasy; methamphetamine / amphetamine; LSD; 
magic mushrooms; heroin; subutex / suboxone without a prescription; methadone 
without a prescription; Relevin; volatile compounds (toluene, solvents, adhesives, 
etc.); depressant drugs without a prescription such as Diazepam, Neurol, Rohypnol, 
Lexaurin,Codeine, Tramal and other drugs: which(....).
Denmark Tried [drug] ever -  yes  -   no
Alcohol; hashish, all forms of cannabis; amphetamines; Cocaine; ecstasy = MDMA, 
etc; LSD; magic mushrooms; benzodiazepines (all preparations) (illegally); heroin, 
opium, and all forms, "Pakistani-pills" etc.; morphine / Ketogan / Contalgin (illegal); 
Temgesic (= Subutex = buprenorphine = anorfin )   (illegal); methadone (illegal); 
Solvents /lighter fluid; other drugs (write).
Germany : : :
Estonia : : :
Ireland : : :
Greece : : :
Spain Did you use [drug] any time in your life? -  yes  -   no
Alcohol; non prescribed tranquilizers (benzodiazepines: Trankimazin, Rohypnol, 
diazepam, Valium, Tranxilium, Orfidal, Halcion or barbiturates; cannabis (hashish, 
marijuana, joint, oil, weed), heroin (without any other drug), non prescribed 
methadone (street methadone), non prescribed opiates (other than heroin and 
methadone) morphine, codeine, Contugesic, opium, buprenorphine, pentazocine, 
Buprex, Deprancol, pethidine); cocaine base (without heroin); cocaine powder 
(without heroin), heroin+cocaine (mix in the same dose), amphetamines (speed, 
methamphetamine, ice, Dexedrine, Centramine); ecstasy (MDMA, MDA); 
hallucinogens (LSD, acid, peyote, mescaline, magic mushrooms); inhalants 
(poppers, nitrates, solvents, gasoline, glues).
France Before entering the prison was the patient taking the following [drug]? -  yes  -   no Heroin; cocaine; crack, free-base; other.
Italy : : :
Cyprus : : :
Latvia Before entering the prison have you ever tried [drug]? -  yes  -   no
Alcohol (beer, alcoholic cocktails, wine, cider, vodka and other spirits); marijuana or 
hashish, "grass"; ecstasy; amphetamines; cocaine; heroin; opiates; analgesic and 
sedating drugs without a prescription.
Lithuania : : :
Luxembourg : : :
Hungary Have you ever used drugs? - If you have used, which drugs have you 
used? Yes, for the last time before imprisonment. 
Heroin (hernyó, herka, barna, nyalcsi); methadone; cocaine (kokó, koksz, kóla); 
amphetamines (speed, spuri, gyors, amfet, ice); ecstasy (labda, laszti, bogyó, gömb, 
tabi, X, ex, XTC); cannabis (spangli, fű, csoki, kender, zöld, haska, joint, dzsó); LSD 
(bélyeg, korong, tripp, papír); other (namely).
Malta : : :
Netherlands : : :
Austria : : :
Poland : : :
Portugal What is your situation regarding drug consumption? -  I have never in my life consumed any drugs  
-  I have consumed drugs
Cannabis (marijuana, hashish, weed); medicines (pills), cocaine (coca), heroin 
(hero, horse), amphetamines (LSD, acids), ecstasy (tablets, speeds), other 
substances (e.g. glue, solvents).
Romania Have you ever used one or more of the substances mentioned on the card (mark the appropriate code)? -  yes  -   no
Heroin, cocaine, LSD, cannabis (marijuana), hashish, ecstasy, amphetamines, 
relevin, Methadone, other type of drug, please specify.
Slovenia : : :
Slovakia : : :
Finland : : :
Sweden Have you ever tried preparation? - no  - yes Methadone, Subutex, other opiates / analgesics, hypnotic and sedatives (BZD, Sed, Hypn.), cocaine, amphetamine, cannabis, hallucinogens, ecstasy, solvents, other
United Kingdom
(England & Wales) Before entering custody, had you ever used any of these drugs? -  yes  -   no
Amphetamines (also known as speed, whizz, upper, Billy); cannabis (also know as 
marijuana, grass, hash, ganja, blow, draw, skunk, weed, spliff); crack cocaine (also 
known as rock, stones, white); cocaine (also known as Charlie, C); ecstasy (also 
known as E, pills); heroin (also known as smack, skag, H, Brown, horse); LSD (also 
known as tabs, trips) or magic mushrooms; unprescribed methadone; unprescribed 
tranquilizers (also known as diazepam, temazepam, ‘downers’, ‘jellies’, ‘temmazies’, 
‘tranks’); None of these; Don’t know; Not stated/refused.
Croatia : : :
Turkey : : :
Norway : : :
A fake drug was used by two questionnaires, to filter out people who said they had tried every 
drug and to ensure the validity of the prisoners’ answers.  
 
Table 4. Questions regarding lifetime drug use 
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3.3.2 Drug use inside prison (Table 5)  
The following countries included questions related to prisoners’ drug use inside prison: 
Belgium, Bulgaria, the Czech Republic, Estonia, Spain, Latvia, Lithuania, the Netherlands, 
Portugal, Romania, Sweden and the United Kingdom (England and Wales). The wording was 
unambiguous. The questions included all the necessary information and were tailored to 
prisoners’ reading skills.  
Clarity of wording 
All questions differed between countries in the number of words and phrasing used. However, 
in seven countries the questions started with or included the same clause: ‘Have you ever’. 
The questions varied between countries regarding the wording; for example, for ‘lifetime 
prevalence’ different expressions were used: ‘have you ever’ (the most frequent), ‘ever’, ‘in 
your life’ or ‘during the life’. None of the questionnaires used the same phrases. The 
sentences varied from very short questions like ‘What did you use mostly in this year?’ (the 
Netherlands), to a combination of several questions like: ‘Have you ever in your life, inside or 
outside prison, used other drugs than alcohol (all illegal drugs, also marihuana and hashish)?’ 
and ‘Which drugs have you ever used in your life?’ (Belgium) (see Table 5).  
Polar questions 
Eight questionnaires included polar questions. The order of the answers (‘yes’ or ‘no’) 
differed, with three countries presenting ‘no’ as the first option, and five putting ‘yes’ first. 
Biases 
In all countries the response categories were clear and mutually exclusive, and no bias was 
detected.  
Number and type of drugs 
The list of drugs in some cases was very extensive. It could vary from 0 to 15 drugs. Lithuania 
only referred to ‘psychoactive substances’ without specifying any particular drug; other 
countries, such as Belgium and Spain, included a complete list of substances. All countries 
included heroin, cannabis, cocaine and amphetamines. Questions related to ecstasy were 
included in at least one-third of the surveys. Three countries (Bulgaria, the Czech Republic 
and Spain) included methamphetamine, and three countries (France, Spain and the United 
Kingdom) referred to crack use. Only three member states asked about alcohol use (the 
Czech Republic, Spain and Latvia). Questions about the use of non-prescribed medicines and 
methadone were included by less than one-third of the countries.  
A fake drug was used by two questionnaires, to filter out people who said they had tried every 




Inside prison Questions Answers Drugs
Belgium
Have you ever in your life, inside or outside prison, 
used other drugs than alcohol (all illegal drugs, also 
marihuana and hashish)?
  -   no  -   yes
Heroin; cocaine, crack; speed, amphetamines; ecstasy; GHB (liquid XTC); LSD or 
mushroom; methadone or Subutex: black market; hashish, marihuana; sleeping 
pills or sedatives of the black market; Valium, Lexotan, (“Roche”); ketamine; self-
prepared mixtures;
Bulgaria Have you ever used DRUGS in lifetime?
-    Never                                                                            
 -   at least once  
 -   at least 10 times in the last month or at least 30 times in the last year 
Cannabis (marijuana, hashish, ganja); cocaine (including crack); heroin; ecstasy; 
others (morphine, codeine, lido, methadone substitol, methamphetamine, LSD, 
hallucinogenic mushrooms, adhesives, bronze, etc.)..
Czech Republic Have you ever taken some of these substances in prison.   -   no  -   yes
Alcohol; marijuana / hashish; ecstasy; methamphetamine / amphetamine; LSD, 
Magic mushrooms; heroin; Subutex / Suboxone without a prescription; methadone 
without a prescription; Relevin; volatile compounds (toluene, solvents, adhesives 
etc.); depressant drugs without a prescription such as: Diazepam, Neurol, 
Rohypnol, Lexaurin, Codeine, Tramal; Other drugs, which:.
Denmark : : :
Germany : : :
Estonia
Have you ever used drugs in prison (including hemp 
products)?
Think of all the times spent in prison.   -   yes  -   no :
Ireland : : :
Greece : : :
Spain In the last 30 days in prison did you use [drug] ?   -  yes  -   no
Alcohol; non prescribed tranquilizers (benzodiazepines: Trankimazin, Rohypnol, 
diazepam, Valium, Tranxilium, Orfidal, Halcion or barbiturates; cannabis (hashish, 
marijuana, joint, oil, weed), heroin (without any other drug), non prescribed 
methadone (street methadone), non prescribed opiates (other than heroin and 
methadone) morphine, codeine, Contugesic, opium, buprenorphine, pentazocine, 
Buprex, Deprancol, pethidine); cocaine base (without heroin); cocaine powder 
(without heroin), heroin+cocaine (mix in the same dose), amphetamines (speed, 
methamphetamine, ice, Dexedrine, Centramine); ecstasy (MDMA, MDA); 
hallucinogens (LSD, acid, peyote, mescaline, magic mushrooms); inhalants 
(poppers, nitrates, solvents, gasoline, glues).
France : : :
Italy : : :
Cyprus : : :
Latvia Did you in prison time ever tried [drug]?   -  yes  -   no
Alcohol (beer, alcoholic cocktails, wine, cider, vodka and other spirits); marijuana or 
hashish, "grass"; ecstasy; amphetamines; cocaine; heroin; opiates; analgesic and 
sedating drugs without a prescription.
Lithuania The primary psychoactive substance due to which the person applied to the health care institution : :
Luxembourg : : :
Hungary : : :
Malta : : :
Netherlands What did you use mostly in this year? : Heroin, cocaine, other opiates (morphine, opium, etc), amphetamines (speed), 
anabolic steroids, Other drug; namely.
Austria : : :
Poland : : :
Portugal What is the situation that most resembles your case?
-   Never consumed                                                                                              
-   Consumed before prison but stopped consuming before prison           
-   Consumed before prison but stopped consuming in prison      
-   Consumed before prison and continued or consumed again in prison
-   Consumed for the first time in prison
Cannabis (marijuana, hashish, weed); medicines (pills), cocaine (coca), heroin 
(hero, horse), amphetamines (LSD, acids), ecstasy (tablets, speeds), other 
substances (e.g. glue, solvents).
Romania Have you ever consumed [drug] while in current detention?     -  yes  -   no
Heroin, cocaine, LSD, cannabis (marijuana), hashish, ecstasy, amphetamines, 
relevin, Methadone, other type of drug, please specify.
Slovenia : : :
Slovakia : : :
Finland : : :
Sweden
How many of the last 30 days have you used [drug]? 
Did you use it on a physician prescription? Have you 
followed this prescription?
- no  - yes Methadone, Subutex, other opiates / analgesics, hypnotic and sedatives (BZD, Sed, Hypn.), cocaine, amphetamine, cannabis, hallucinogens, ecstasy, solvents, other
United Kingdom
(England & Wales)
Have you used any of these [drugs] while you have 
been in prison for your current sentence? -  yes  -   no
Amphetamines (also known as speed, whizz, upper, Billy); cannabis (also know as 
marijuana, grass, hash, ganja, blow, draw, skunk, weed, spliff); crack cocaine (also 
known as rock, stones, white); cocaine (also known as Charlie, C); ecstasy (also 
known as E, pills); heroin (also known as smack, skag, H, Brown, horse); LSD (also 
known as tabs, trips) or magic mushrooms; unprescribed methadone; unprescribed 
tranquilizers (also known as diazepam, temazepam, ‘downers’, ‘jellies’, ‘temmazies’, 
‘tranks’); None of these; Don’t know; Not stated/refused.
Croatia : : :
Turkey : : :
Norway : : :
Table 5. Questions regarding drug use in prison 
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3.3.3 Frequency of drug use before entering prison/while in prison (Table 6)  
The frequency of drug use represents an important item of information on drug use patterns. 
The standard method for data collection is based on the ranking of frequencies. Ten countries 
included questions regarding the prisoners’ frequency of drug use. Three (Latvia, Sweden 
and the United Kingdom) included several questions referring to the frequency of drug use for 
a specific reference period (usually the last month).   
Clarity of wording  
In all cases the wording was unambiguous and included all the necessary terms to be clear 
and understandable. The questions were adapted to prisoners’ educational ability. The 
wording differed in every country, including expressions like ‘frequency of intake’, ‘how 
frequent’, ‘how often’ and ‘how many’.  
Biases 
In all countries the response categories — ranking of frequencies — were clear and mutually 
exclusive, and no bias was detected. However, the way in which frequency was defined 
differed between countries. Frequency of drug use progressed from ‘never’ to ‘occasional 
(monthly) use’, ‘one time a month’, ‘less than one day a week’, ‘once weekly or less’; and to 
more frequent drug use: weekly might be ‘four to six days a week’ or ‘four times a week or 
more’ and daily was also expressed as ‘every day’. Some countries used ‘times’ to express 
the frequency (Belgium, Bulgaria, the Czech Republic, Denmark, and Latvia), others used 
‘days’ (Spain and the United Kingdom), and others mixed the two measures. Sweden used 
the two formulations ‘times’ and ‘days’. The Netherlands only asked which is the most 
frequently used drug in the year; Portugal asked about the situation that best described the 
prisoners’ frequency of drug use. Some of the categories used were not accurate and were 
rather ambiguous (e.g. ‘Repeatedly during last months before onset’). Nine countries used 
close-ended answers, while two (Sweden and the United Kingdom) used open-ended 
questions. Only two countries included the options ‘don’t know’ and ‘no answer’ or ‘not 
stated/refused’.  
Number and type of drugs 
The list of drugs for which the frequency of use was asked about was in some cases very 
extensive. The number could vary from a few to 15 drugs. Spain included the longest list of 
different substances. Of the ten countries that asked about the number and type of drugs 
used, nine asked about the frequency of use of heroin, cocaine, cannabis products, 
amphetamine and ecstasy; only three countries asked about the frequency of use of 
methamphetamine (Bulgaria, the Czech Republic and Spain), crack (cocaine base) (Belgium, 
Spain and the United Kingdom) or alcohol (Denmark, Spain and the Czech Republic). Some 





Have you during your current stay in prison; use any 
drugs (no alcohol but all illegal drugs, also 
marihuana and hashish) that were available on the 
black (illegal) market in the prison?
- Never
 -   Ever, but not the past year (last 12 months)
 -   1 time per month or less
 -   Multiple times per month
 -   1 time per week
 -   Multiple times per week
 -   Daily
Heroin; cocaine, crack; speed, amphetamines; ecstasy; GHB (liquid XTC); 
LSD or mushroom; methadone or Subutex: black market; hashish, 
marihuana; sleeping pills or sedatives of the black market; Valium, Lexotan, 
(“Roche”); ketamine; self-prepared mixtures;
Bulgaria Have you ever used DRUGS in lifetime?
 -    Never                                                                            
 -   at least once  
 -   at least 10 times in the last month or at least 30 times in the last year 
Cannabis (marijuana, hashish, ganja); cocaine (including crack); heroin; 
ecstasy; others (morphine, codeine, lido, methadone substitol, 
methamphetamine, LSD, hallucinogenic mushrooms, adhesives, bronze, 
etc.)..
Czech Republic
Please circle whether you have before entering 
prison taken one of the listed substances.
 -   Repeatedly during last months before onset 
 -   1-2 times during last months before onset 
 -   During last year before onset
 -   During the lifetime before onset
 -   Never 
Alcohol; marijuana / hashish; ecstasy; methamphetamine / amphetamine; 
LSD, Magic mushrooms; heroin; Subutex / Suboxone without a prescription; 
methadone without a prescription; Relevin; volatile compounds (toluene, 
solvents, adhesives etc.); depressant dr
Denmark Frequency of intake [drug] last month before insertion  
-   Once weekly or less
-   2-6 times per week
-   Daily
Alcohol; hashish, all forms of cannabis; amphetamines; cocaine; ecstasy = 
MDMA, etc; LSD; magic mushrooms; benzodiazepines (all preparations) 
(illegally); heroin, opium, and all forms, "Pakistani-pills" etc.; morphine / 
Ketogan / Contalgin (illegal); Temgesic (= Subutex = buprenorphine = 
anorfin )   (illegal); methadone (illegal); Solvents /lighter fluid; other drugs 
(write).
Germany : : :
Estonia : : :
Ireland : : :
Greece : : :
Spain How frequent was your use of [drug] in the 30 days before this last imprisonment?
-   Less than one day a week
-   1-3 days a week
-   4-6 days a week
-   Every day
-   No answer
-   Don't know
Alcohol; non prescribed tranquilizers (benzodiazepines: Trankimazin, 
Rohypnol, diazepam, Valium, Tranxilium, Orfidal, Halcion or barbiturates; 
cannabis (hashish, marijuana, joint, oil, weed), heroin (without any other 
drug), non prescribed methadone (street methadone), non prescribed 
opiates (other than heroin and methadone) morphine, codeine, Contugesic, 
opium, buprenorphine, pentazocine, Buprex, Deprancol, pethidine); cocaine 
base (without heroin); cocaine powder (without heroin), heroin+cocaine (mix 
in the same dose), amphetamines (speed, methamphetamine, ice, 
Dexedrine, Centramine); ecstasy (MDMA, MDA); hallucinogens (LSD, acid, 
peyote, mescaline, magic mushrooms); inhalants (poppers, nitrates, 
solvents, gasoline, glues).
France : : :
Italy : : :
Cyprus : : :
Latvia
How often you used [drug] in the last month prior to 
imprisonment?
How often did you take  [drug] in the past month in 
prison?
-   I use several times a day
-   Daily
-   4-6 times a week
-   2-3 times a week
-   At least once a week
-   Less than once a week
Marijuana or hashish, "grass"; ecstasy; amphetamines; cocaine; heroin; 
opiates; analgesic and sedating drugs without a prescription.
Lithuania : : :
Luxembourg : : :
Hungary : : :
Malta : : :
Netherlands What did you use mostly in this year? : Heroin, cocaine, other opiates (morphine, opium, etc), amphetamines (speed), anabolic steroids, Other drug; namely.
Austria : : :
Poland : : :
Portugal What is the situation that most resembles your case?
-   Never consumed                                                                                              
-   Consumed before prison but stopped consuming before prison           
-   Consumed before prison but stopped consuming in prison      
-   Consumed before prison and continued or consumed again in prison
-   Consumed for the first time in prison
Cannabis (marijuana, hashish, weed); medicines (pills), cocaine (coca), 
heroin (hero, horse), amphetamines (LSD, acids), ecstasy (tablets, speeds), 
other substances (e.g. glue, solvents).
Romania : : :
Slovenia : : :
Slovakia : : :
Finland : : :
Sweden
How often do you use [drug] other than alcohol? 
How many of the last 30 days have you used [drug]? 
Did you use it on a physician prescription? Have you 
followed this prescription?
How many years have you used  [drugs]  three days 
or more per week? How many of these have you 
followed the prescription?
-   Never  -   1 time a month or less  -   2-4 times month 
-   2-3 times week  -   4 times / week or more
-   Number of days:__ __
-   Number of years:__ __
Methadone, Subutex, other opiates / analgesics, hypnotic and sedatives 




On how many days did you use cannabis in the four 
weeks before you came into custody?
 
On how many days have you used <DRUG> in the 
last four weeks?
-   Number of days …
-   don't know
-   not stated/refuse
Amphetamines (also known as speed, whizz, upper, Billy); cannabis (also 
know as marijuana, grass, hash, ganja, blow, draw, skunk, weed, spliff); 
crack cocaine (also known as rock, stones, white); cocaine (also known as 
Charlie, C); ecstasy (also known as E, pills); heroin (also known as smack, 
skag, H, Brown, horse); LSD (also known as tabs, trips) or magic 
mushrooms; unprescribed methadone; unprescribed tranquilizers (also 
known as diazepam, temazepam, ‘downers’, ‘jellies’, ‘temmazies’, ‘tranks’); 
None of these; Don’t know; Not stated/refused.
Croatia : : :
Turkey : : :
Norway : : :
Kingdom) included the frequency of use of non-prescribed medicines (benzodiazepines, 
hypnotic, antiparkinsonian, methadone and buprenorphine).  
Table 6. Frequency of drug use before entering/while in prison  
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3.3.4 Initiation of drug use inside prison 
There is considerable political concern about prisoners who take drugs for the first time whilst 
in prison. Five countries included questions on drug initiation inside prisons in their surveys.  
Clarity of wording 
None of the wording used in the questions matched. Phrases used included ‘first time was in 
prison’, ‘first have tried drugs were you in prison’, ‘consumed for the first time in prison’, ‘first 
use in prison’ or ‘was the first time you ever used heroin in prison’.  
Number and type of drugs 
Four countries (Belgium, Estonia, Portugal, Spain) included questions about the most 
common drugs used for the first time in prison: cannabis, heroin, cocaine, amphetamine and 
ecstasy. Belgium, Portugal and Spain asked about a range of different drugs: Spain included 
a question about drinking alcohol for the first time in prison; Belgium and Spain also included 
non-prescribed methadone and other medicines; and Portugal asked about medicines. The 
United Kingdom only asked the prisoners whether the first time they ever used heroin was in 
prison.  
3.3.5 Route of administration/injecting drugs before entering or while in prison (Table 
7)  
Twelve countries included questions regarding the main method of drug administration, or 
drug injection.  
Clarity of wording 
None of the wording used in the questions matched. Phrases used included ‘typical mode of 
administration’, ‘methods of consumption’, ‘frequent route for drug intake’ or ‘which route of 
administration’. Six countries asked whether the respondent injected drugs. Different words 
were used to refer to the route of drug administration, and no harmonisation was found. Polar 
questions were used for injecting behaviours. Some countries asked about other routes of 
administration, which could be specified by the respondent.  
Number and type of drugs 
Seven countries included a list of drugs and asked respondents to indicate how they took 
them. Cocaine, ecstasy, heroin, cannabis and amphetamine were the most commonly 





How do you use heroin in prison (more than one 
answer is possible)?
Have you ever injected drugs (intravenous)?
-   Injecting
-   Inhaling
-   Other (fill in)………
-  yes  -   no
Heroin
Bulgaria Have you ever used in lifetime a  NARCOTIC INJECTION?
-   Never
-   Some time ago
-   Currently
:
Czech Republic
Have you ever injected any drug?
Have you ever injected any drug in prison?
-  no  -   yes :
Denmark Typical mode of administration last month before insertion 
-   Injection
-   Smoking
-   Sniffing
-   Eat/drink substance
Hashish, all forms of cannabis; amphetamines; cocaine; ecstasy = MDMA, 
etc; LSD; magic mushrooms; benzodiazepines (all preparations) (illegally); 
heroin, opium, and all forms, "Pakistani-pills" etc.; morphine / Ketogan / 
Contalgin (illegal); Temgesic (= Subutex = buprenorphine = anorfin )   
(illegal); methadone (illegal); Solvents /lighter fluid; other drugs (write).
Germany : : :
Estonia : : :
Ireland : : :
Greece : : :
Spain
By which route did you use [drug] more frequently in 
the 30 days before this last imprisonment?
By which route did you use [drug] more frequently in 
the last 30 days?
-   Smoke on aluminum foil, pipe, vase, bottle
-   Smoke by cigarette
-   Injected
-   Sniffed through the nose
-   Oral (through the mouth)
-   Another
-   No answer
-   Don't know
Alcohol; non prescribed tranquilizers (benzodiazepines: Trankimazin, 
Rohypnol, diazepam, Valium, Tranxilium, Orfidal, Halcion or barbiturates; 
cannabis (hashish, marijuana, joint, oil, weed), heroin (without any other 
drug), non prescribed methadone (street methadone), non prescribed 
opiates (other than heroin and methadone) morphine, codeine, Contugesic, 
opium, buprenorphine, pentazocine, Buprex, Deprancol, pethidine); cocaine 
base (without heroin); cocaine powder (without heroin), heroin+cocaine (mix 
in the same dose), amphetamines (speed, methamphetamine, ice, 
Dexedrine, Centramine); ecstasy (MDMA, MDA); hallucinogens (LSD, acid, 
peyote, mescaline, magic mushrooms); inhalants (poppers, nitrates, 
solvents, gasoline, glues).
France Before entering prison, did the patient use drugs by intravenous route in lifetime? -  yes  -   no :
Italy : : :
Cyprus : : :
Latvia
How did you use [drug] before entering prison? 
How you used [drug] during detention?
-   Snorted
-   Injected (duroties)
-   In tablets 
-   Other (which?)
Ecstasy; amphetamines; cocaine; heroin; opiates; analgesic and sedating 
drugs without a prescription.
Lithuania : : :
Luxembourg : : :
Hungary : : :
Malta : : :
Netherlands
Have you ever injected drugs or steroids? 
Have you ever injected drugs or steroids in 
detention?
Have you ever injected drugs or steroids during this 
detention?
-   No 
-   Yes, drugs
-   Yes, steroids
-   No
-   Yes, indicate what you have injected……………………..
:
Austria : : :
Poland : : :
Portugal Methods of consumption before this reclusion?
-   Smoking
-   Snorting/Inhaling
-   Injecting
-   Ingesting
Cannabis (marijuana, hashish, weed); medicines (pills), cocaine (coca), 
heroin (hero, horse), amphetamines (LSD, acids), ecstasy (tablets, speeds), 
other substances (e.g. glue, solvents).
Romania
Which route of administration did you use to 
consume drugs? 
-  for regular consumption 
-  for occasional consumption
-   Oral; Oral ingestion of the drug by mouth (tablets / pills)
-   Parenteral or injectable (intravenous, intramuscular, subcutaneous or 
intradermal)
-   Intra-nasal snuff (powder suction through the nose)
-   Smoking (suction gas, vapour)
-   Inhalation (trailing)
-   Other (specify)
-   did not consume
-   NR
Heroin, cocaine, ecstasy, ethnobotanical, other type of drug
Slovenia : : :
Slovakia : : :
Finland : : :
Sweden
Which was the most frequent route for [drug] intake?
Have you ever injected?
-   Oral
-   Nasal
-   Smoking
-   Non intravenous injection
-   Intravenous injection
- no  - yes
Methadone, Subutex, other opiates / analgesics, hypnotic and sedatives 




How did you normally take [drug]?
Have you injected any drugs while you have been in 
prison for your current sentence?:
-   Swallow
-   Snort/sniff
-   Smoke/chase
-   Inject
-   Not stated/refused
-  yes  -   no
Amphetamines (also known as speed, whizz, upper, Billy); cannabis (also 
know as marijuana, grass, hash, ganja, blow, draw, skunk, weed, spliff); 
crack cocaine (also known as rock, stones, white); cocaine (also known as 
Charlie, C); ecstasy (also known as E, pills); heroin (also known as smack, 
skag, H, Brown, horse); LSD (also known as tabs, trips) or magic 
mushrooms; unprescribed methadone; unprescribed tranquilizers (also 
known as diazepam, temazepam, ‘downers’, ‘jellies’, ‘temmazies’, ‘tranks’); 
None of these; Don’t know; Not stated/refused.
Croatia : : :
Turkey : : :
Norway : : :
Table 7. Route of administration/injecting drugs before entering or while in prison  
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3.3.6 Risk behaviours in drug use (other than injecting) (Table 8)  
Ten countries included questions about risk behaviours, referring to different time periods: 
lifetime, last six months, last two months, last month.  
Questions about injecting drugs varied between countries. Most of the countries asked 
prisoners whether they shared and disinfected or cleaned syringes. Other questions were 
linked to re-use of syringes, sharing equipment like cookers, cottons and filters, sharing 
liquids to clean syringes and occasionally about whether users loaded the drug from used 
syringes or cookers. Only five countries included questions related to tattooing and if the 
instruments were disinfected before use. Two asked about piercing. One country asked about 
hygiene habits, namely toothbrush use. Some countries asked questions about sexual 
practices — five asked about sexual practices in exchange for money to sustain drug use or 
to purchase drugs; one asked about non-consensual sex.  
Clarity of wording  
In all cases the wording of the questions was not ambiguous and included all the necessary 
terms to be clear and understandable.   
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Related to drug use Not related to drug use Not related to drug use
Belgium
-   Have you the last time you injected, before your stay in prison, 
shared your injection equipment (syringe, spoon, filter, water) with 
anyone?
-   Have you the last time you injected drugs in prison, disinfected the 
injection equipment?
-   Have you been during your current stay in prison tattooed or being 
tattooed?
-   Have you during your current stay in prison pierced or got pierced?
-   Have you during your current stay in prison ever shared a toothbrush or a 
razor (used together) with another prisoner?
-   Have you during your current stay in prison ever received money or goods 
in return for sexual practices?
-   Have you during your current stay in prison had sexual relations, but 
outside the conjugal visits?
-   If yes, did you use condoms?
Bulgaria : : :
Czech Republic
-   Have you ever used needle or syringe, which previously used by 
someone else?
-   Have you ever in prison used needle and syringe previously used 
by someone else?
: :
Denmark : : :
Germany : : :
Estonia
-  Did you, in the last 12 months in prison, inject with a needle or 
syringe that had been used by someone else before you?
-  Did you, in the last 12 months in prison, fill your syringe from 
another syringe which was used before to inject or to fill others 
syringes?
-  Did you, in the last 12 months in prison, use cookers used by 
someone else before you? 
-  Did you, in the last 12 months in prison, use filters or cottons, 
which were used by someone else before you?
-  Did you, in the last 12 months in prison, take a drug solution from a 
cooker, which somebody before you put a needle in?
-   Have you ever in prison get a tattoo done on your own?
-   Were the instruments cleaned before the last prison tattoo?
-   Have you ever made in prison holes into the body (eg
ear, lip, navel, etc.)?
-   How were instruments  (needles clips, safety pins, etc.) cleaned before 
the last piercing in prison?
-   You have in the last 12 months in prison had sexual intercourse with 
several different people? 
-   How often was a condom used the last 12 months for sexual intercourse?
-   How often was a condom used the last 12 months in prison in sex with 
same-sex person?
Ireland : : :
Greece : : :
Spain
-  When in prison, over the last 30 days did you inject with needles or 
syringes already used by other inmates?
-  When in prison, over the last 30 days, before injection, did you 
clean the needles or syringes already used by other inmates?
-  Over the last 30 days in prison, did you inject drugs that were 
dissolved in a syringe already used by another inmate?
-  Over the last 30 days in prison, did you use spoon, can, recipient 
to cook/dilute the drug already used by another inmate?
-  Over the last 30 days in prison, did you use filter or cotton already 
used by another inmate?
-  Over the last 30 days in prison, did you use liquid to clean the 
syringe already used by another inmate?
-   Did you have a tattoo done in prison?
-   Do you know whether or not the needle was disinfected?
-  Over the last 12 months, did you have oral or anal sexual intercourse?
-  Did you use condoms in our sexual intercourses over the last 12 months?
France : : :
Italy : : :
Cyprus : : :
Latvia
-  Did you in jail clean the syringe and needle and use it again?
-  Or in prison, using drugs, you should always use a syringe that you 
use only your own?
-  Or in prison time you ever used a syringe and needle, which is 
used by other prisoners?
-  How do you clean the syringe and needle?
Lithuania : : :
Luxembourg : : :
Hungary
-   Before imprisonment, have you ever shared needles or syringes?  
-   Before imprisonment, have you ever shared other injecting 
equipments (such as: spoons/filters/cooker/water)? 
-   During this imprisonment have you ever shared needles or 
syringes? 
-   During this imprisonment have you ever shared other injecting 
equipments (such as: spoons/filters/cooker/water)?
 -   Do you have tattoos?
-  When did you have your last sexual intercourse?
-  At your last sexual intercourse, did you or your partner use a condom on 
that occasion?
-  Do you usually use a condom with your casual sex partner?  
Malta : : :
Netherlands
-   Have you ever lent needles or syringes to other detainees while in/ 
in this detention?
-   Did you have any syringes or needles used by other prisoners 
while in/ in this detention ?
-   How often do you have in this detention during injection, used 
materials (eg, spoon, glass, water and cotton balls) borrowed from 
someone?
-   Are the used syringes and needles when pre-cleaned?
-   How are these syringes or needles mainly cleaned?
 - If an official tattoo artist would be in jail, would you then use it?
 - If an official piercer would be in jail, would you then use it?
-  Have you ever had one of the following sexual acts other than during BZT 
made within detention?
-  Have you ever had one of the following sexual acts against your wishes in 
detention?  
Austria : : :
Poland : : :
Portugal
-   Over the last month, in order to inject, you used more often 
new/used needles?
-   Over the last month, did you share needles with another person?
-   Over the last month, how many times did you use a disinfectant 
(bleach or another) to clean the needles?
: :
Romania : : :
Slovenia : : :
Slovakia : : :
Finland
Sweden If you take the last six months, how often have you shared syringe? : :
United Kingdom
(England & Wales)
-   How many times did you inject with a needle already used by 
someone else?
-   Did you share any injecting equipment (spoon, filter, syringe or 
needle) with anyone else?
-   Did you use disinfecting tablets to clean injecting equipment?
: :
Croatia : : :
Turkey : : :
Norway : : :
Table 8. Risk behaviours in drug use (other than injecting)   
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3.3.7 Drug overdose  
Drug overdoses occur in prison, and most cases involve heroin. Some of these overdoses 
may be linked to suicides attempts. Despite the relevance of the issue from a public health 
perspective, there were very few, limited questions about it, perhaps due to the complexity of 
the topic and the difficulty in collecting information on it . Only two countries, Belgium and the 
United Kingdom, asked about drug overdoses.   
Belgium asked about overdoses during the current period of imprisonment. The United 
Kingdom included three different questions to explore overdoses. The first question asked 
about all overdoses — ‘Have you ever overdosed on drugs?’; the second about frequency of 
overdoses — ‘How many times? Once; two or three time; four or five times; six to nine times; 
10 or more times?’ The United Kingdom also asked inmates about their opinion on the 
distribution of naloxone in prison: ‘In your opinion, could giving out ampoules of naloxone at 
needle exchanges save lives?’  
3.3.8 Psychiatric comorbidity  
Mental health disorders are quite prevalent among prison inmates, and the level and severity 
of these disorders are the subject of several studies. Psychiatric comorbidity is also an 
important issue in prisons (EMCDDA, 2012).  
Six countries included scales or questions to assess psychiatric comorbidity.   
Clarity of wording 
There was no harmonisation on how this information was collected — the issues, scales, 
wording of questions and answer categories all differed. 
Belgium asked whether prisoners were weary and restless, what their mental condition was in 
the last month, what their subjective feeling of boredom and their mental state was. Finland 
included a psychiatric assessment scale about regular use of medication for mental disorders, 
past mental treatment, and inmates’ perception of their mental health. Latvia included a short 
assessment scale and questions about the prevalence of some psychiatric disorders and 
symptoms (e.g. depression, anxiety, aggression, insomnia and suicidal thoughts). Romania 
asked about lifetime treatment for psychiatric disorders. The Swedish survey included a 
section on mental health that included two questions on the number of treatments received in 
mental health centres and one on the lifetime and current (last 30 days) experience of severe 
depression, experiencing severe anxiety or stress, experiencing difficulties in understanding, 
remembering or concentrating, experiencing hallucinations, and experiencing difficulty 
controlling violent behaviours. The United Kingdom (England and Wales) asked about the 
frequency of visits to GP/family doctor for health or medical problems, including mental health 
and emotional problems, and whether the respondent had been prescribed medication for 
mental health and emotional problems, and if so the type and name of medication and 
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continuation of prescription. Some countries included screening scales for detecting 
psychosis, anxiety and depression. Questions on this topic in all the questionnaires referred 
to the last 12 months before entering in prison.   
3.3.9 General questions: socio-demographic (Table 9)  
Socio-demographic questions featured in all the surveys, asking about gender, birth year 
and/or age, nationality and/or place of birth, level of education, employment status and living 
conditions.  
All countries except three asked for the respondent’s gender. All countries except two asked 
for their age or birth year. Ten asked about level of education. Nationality was also asked for 
by seven countries. Six collected data on respondents’ employment status prior to entering 
prison. Some countries asked questions relating to where people lived before entering prison, 





Gender Birth year/ age Nationality
Highest level 





Belgium √ √ : : : : :
Bulgaria : √ : : : : :
Czech Republic √ √ √ √ √ : :
Denmark √ √ : : : : :
Germany : : : : : : :
Estonia √ √ √ √ : : :
Ireland √ √ : : : : :
Greece : : : : : : :
Spain √ √ √ √ √ √ √
France √ √ : : : : :
Italy : : : : : : :
Cyprus : : : : : : :
Latvia : √ √ √ √ √ √
Lithuania : : : : : : :
Luxembourg : : : : : : :
Hungary √ √ : : : : :
Malta : : : : : : :
Netherlands : √ √ √ : : :
Austria : : : : : : :
Poland : : : : : : :
Portugal √ √ √ √ : √ √
Romania √ √ √ √ : √
Slovenia : : : : : : :
Slovakia : : : : : : :
Finland √ √ : √ √ √
Sweden √ √ : √ √ √ √
United Kingdom
(England & Wales) √ √ : √ √ √ √
Croatia : : : : : : :
Turkey : : : : : : :
Norway : : : : : : :




3.3.10 Type of offences related to drug use (Table 10)  
The links between drugs and crime are complex. Studies that have been carried out to collect 
reliable data on this issue are typically based on prisoners. Several of the surveys that were 
assessed for this study included questions dealing with the relationship between drugs and 
crime.   
Clarity of wording  
There was no uniformity on how data was collected about offences related to illegal drugs. 
Ten countries asked whether the prisoners had been arrested or imprisoned for offences 
linked to illegal drugs. The questions attempted to determine whether the offences were 
committed under the influence of drugs, in order to get money to support drug use or to get 
drugs, or were related to drug dealing, trafficking, cultivation, production, drug use or 
possession for use and/or crimes that included an element of drugs among other issues 
(money laundering, human trafficking, slavery, murder).   
Belgium asked about the reason for the last arrest (possession/use of drugs; drug dealing; 
other reasons; other reason related to drugs). Bulgaria asked about the link between offences 
and drug abuse. Denmark asked whether the crime was committed under the influence of a 
drug (cannabis, cocaine, ecstasy, LSD, heroin, etc.). Finland asked whether a crime had been 
committed to support drugs directly, and about the possession of drugs.   
Some countries asked about the reasons for incarceration. Latvia asked inmates whether 
they had been convicted for drug-related problems. Portugal asked whether imprisonment 
was related to drugs, drug trafficking or other crimes to obtain money to support drug 
consumption, as well as for the related crime: assault, theft, robbery, forgery, swindling, drug 
trafficking, drug consumption, murder, sexual crimes, armed robbery or another type of crime. 
Romania attempted to identify whether the offence was a violent crime, and included a 
question to establish whether the inmate was arrested, and whether the crime was 
committed, under the influence of any substance, and the type of crime committed.  
Some countries asked questions related to their penal code. The Spanish survey categorised 
crimes according to the Spanish penal code: crimes against property or patrimony (robbery, 
theft or fraud); crimes against public health (drug plantations, production or trafficking, 
including precursors); crimes against persons (homicide, murder, abortion, injury); and other 
type of crimes (abuse, harassment and sexual aggression, road safety crime, possession, 
trafficking and holding of guns, terrorism). Sweden grouped crimes as: property offences 
(theft, shoplifting, receiving stolen goods, fraud, etc.); violent crime (robbery, assault, murder, 
manslaughter, etc.); and other types of crimes (vandalism, illegal possession of weapons, 
etc.). The United Kingdom included several questions concerning drug-related offences, 
including selling drugs to anyone including friends, economic-compulsive crimes to support 
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drug use (to steal money or to obtain drugs for themselves or another person) and the 
connection between the offence and the drug/alcohol use.  

















    √ √ √ 
Bulgaria √      √ 
Denmark 
 √      
Spain √      √ 
Latvia √      √ 
Portugal √  √  √ √  
Romania 
 √   √ √ √ 
Finland 
  √  √   
Sweden 
      √ 
United 
Kingdom 
√ √ √     
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4. Concluding remarks 
Based on the results of this assessment, a basic module of a core set of questions was 
defined. The goal was to harmonise the questions that countries had used, in order to collect 
key data related to drug use and related consequences in a harmonised way.   
The assessment did not include all existing instruments available in Europe, but only those 
provided by the countries. However, the variety of questionnaires provided enabled an 
exhaustive analysis of different indicators to be carried out. It is likely that additional 
questionnaires would not significantly affect the overview.  
It is important to note that questionnaires submitted by all but two of the countries had been 
translated into English, and there are limitations related to the translation. In addition, 
methodological differences between the questionnaires, such as the type of interview (face-
to-face, computer-assisted personal interviewing (CAPI), self-administered), could have 
introduced differences in the wording that are not related to actual content differences. 
Nevertheless, the wording of the questions was clear enough to be understandable and 
included all the necessary information.  
Some of the questionnaires were very comprehensive and covered many different areas, 
including areas that are not drug-related.   
In general, the questionnaires differed substantially in many methodological and content 
aspects, but they also presented several similarities and common aspects, as the assessment 
and the tables of comparison have shown. The questions in the proposed common 
questionnaire are based on those commonalities and aim to identify a minimum data set of 
questions that are harmonised at European level.   
The final output of the current analysis is the first draft European questionnaire on drug 
use among prisoners, which includes a limited number of core variables to be implemented 
across countries, either as a stand-alone module on drug use or included in larger prison 
studies addressing broader issues.   
After a preliminary agreement on the questionnaire, the next stage is to develop 
implementation guidelines with methodological specifications and common rules for 
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